BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT05629624 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-08-01 → 2025-01-31 3. primary completion date: 2024-08-01 → 2025-01-31 4. enrollment: 280 → 297 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical